Expert Ratings For Caribou Biosciences
Expert Ratings For Caribou Biosciences
馴鹿生物科學的專家評級
Ratings for Caribou Biosciences (NASDAQ:CRBU) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在過去三個月中，有4位分析師提供了Caribou Biosciences（納斯達克股票代碼：CRBU）的評級，顯示了看漲和看跌的觀點。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表彙總了他們最近的評級，闡明瞭過去30天內情緒的變化，並將其與前幾個月進行了比較。
In the assessment of 12-month price targets, analysts unveil insights for Caribou Biosciences, presenting an average target of $21.5, a high estimate of $24.00, and a low estimate of $19.00. A decline of 6.52% from the prior average price target is evident in the current average.
在對12個月目標股價的評估中，分析師公佈了對Caribou Biosciences的見解，將平均目標價定爲21.5美元，最高估計爲24.00美元，低估值爲19.00美元。目前的平均價格比先前的平均目標股價下降了6.52％。
Exploring Analyst Ratings: An In-Depth Overview
探索分析師評級：深入概述
A comprehensive examination of...
對金融專...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。